Akums Drugs and Pharmaceuticals has announced the incorporation of a wholly-owned subsidiary in Malta, Europe. The subsidiary is named Akums Healthcare Malta Private Limited and was officially registered on October 20, 2025. This strategic move aims to expand the company’s global presence and enhance its operations within the European market.
New European Subsidiary
Akums Drugs and Pharmaceuticals has formally announced the establishment of a new wholly-owned subsidiary in Malta, Europe. This expansion marks a strategic step towards broadening the company’s international footprint.
Subsidiary Details
The newly formed entity is named Akums Healthcare Malta Private Limited. The official date of registration for the subsidiary is October 20, 2025. This incorporation is expected to bolster the company’s ability to serve and expand within the European market.
Source: BSE
